Garcia Borrega, Jorge
Böll, Boris
Kochanek, Matthias
Naendrup, Jan-Hendrik
Simon, Florian
Sieg, Noelle
Hallek, Michael
Borchmann, Peter
Holtick, Udo
Shimabukuro-Vornhagen, Alexander
Eichenauer, Dennis A. http://orcid.org/0000-0002-1927-3514
Heger, Jan-Michel
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 28 June 2022
Accepted: 4 November 2022
First Online: 17 November 2022
Declarations
:
: Given the non-interventional retrospective nature of the study, no ethical approval for its conduct was necessary according to the policy of the ethics committee of the Faculty of Medicine of the University of Cologne. For the same reason, no informed consent had to be obtained from the included patients.
: JGB received research funding and travel support from Kite/Gilead; BB received honoraria, research funding, or travel support from Astellas, Celgene, Janssen Cilag, Johnson & Johnson, Kite/Gilead, MSD, Noscendo, Novartis, Pfizer, Sanofi, and Takeda; MK received honoraria from Astellas, Gilead, MSD, and Pfizer; DAE received honoraria from Sanofi-Genzyme and Takeda; JMH received research funding or travel support from Gilead, Incyte, and Novartis; the other authors declare no potential conflicts of interest.